Profound Medical Announces Key Presentations at SRS2026 to Showcase Technology
The company announced the TULSA Procedure will be highlighted in presentations at the upcoming SRS conference, reinforcing its leadership in robotic prostate cancer treatment. This event provides a platform to demonstrate efficacy and safety data to key physicians and participants.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day